[Principal immunologic factors in carcinogenesis].
D000818:Animals; D000912:Antibodies, Neoplasm; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D001500:BCG Vaccine; D002478:Cells, Cultured; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007165:Immunosuppression Therapy; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D009369:Neoplasms / Q000209:etiology / Q000276:immunology*; D012075:Remission, Spontaneous; D013950:Thymus Gland / Q000502:physiology
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D001500:BCG Vaccine
Les principaux facteurs immunologiques de la cancérogénèse